The Cancer Genetics Program provides counseling and testing for people who may be at risk for a hereditary cancer syndrome. Approximately 5 to 10 percent of all cancers are due to inherited, or genetic, factors. These include breast, colorectal, gynecologic, kidney, pancreatic, pediatric, and prostate cancers.
Some families share a common change, or mutation, in a gene that may increase the risk of developing particular cancers. These mutations are inherited, passed from generation to generation. The types of cancers can vary even within the same family. The program helps at-risk individuals make informed decisions in accordance with their health care needs, preferences, and values.
Contact the Cancer Genetics Program
For an initial genetic evaluation, please call us at 401-444-8361.
Fax for referrals: 401-444-3288
Why is genetic testing important for cancer?
If someone has inherited an increased risk for cancer, there are many options available for early detection or cancer risk reduction. Determining if you are at risk for a hereditary cancer syndrome can provide information that can help with planning regarding:
Cancer screening and surveillance options
Medical management decisions
Diagnostic and treatment options
Identification of at-risk family members
If you are found to have a definite high risk for cancer due to a confirmed hereditary cancer syndrome, you will be referred to our high-risk hereditary cancer syndrome clinic.
Evaluation and Counseling
Genetics evaluation and counseling with a genetics professional involves an analysis of an individual’s personal and family history to determine the risk for a hereditary cancer syndrome.
Genetic testing involves collection of a sample of body fluid, which is then tested to look for variants in genes that are linked to a heightened risk of cancer.
Christine M. Duffy, MD, and Camille Higel-McGovern, RN, MSN, APRN, FNP-C
October 8, 2023
Breast cancer is the most common form of cancer among women in the United States except for skin cancer. About one in eight women, or 13 percent, will develop invasive breast cancer in the course of a lifetime. This year...